Dr. Maria Iren Hella, MD

Dr. Hella practices at Baptist Neurology Inc in Fernandina Beach, Florida.

Dr. Hella's NPI, 1003903949, was assigned on October 10, 2006. Dr. Hella graduated from University of Miami, Miller School of Medicine in 2006. Dr. Hella holds Florida license ME110208.

Dr. Hella's primary practice is Baptist Neurology Inc, at 1340 S 18th St, Fernandina Beach, FL 32034 in Nassau County. The practice phone is (904) 376-3707.

Dr. Hella's primary practice is Baptist Neurology Inc in Fernandina Beach, Florida. Dr. Hella is also affiliated with Baptist Medical Center Jacksonville. The medical group on file is Baptist Neurology. Dmand AI also links Dr. Hella to 1 more hospital and 1 ambulatory surgery center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hella practices, 3 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Hella's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Hella is board certified in epilepsy by the American Board of Psychiatry and Neurology. Dr. Hella is licensed in Florida.

Dmand AI lists cerebrovascular disease, epilepsy, lower back pain, migraine and chronic headache, mobility impairment and parkinson's disease among the conditions Dr. Hella treats.

CMS data shows 551 Medicare services from Dr. Hella across 7 procedure codes in 2024, for 362 Medicare patients. Medicare paid $66,570 for them.

CMS counts 362 Medicare patients who saw Dr. Hella in 2024. The largest group is 75 to 84, with 136 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 19% are also on Medicaid. Their average risk score is 2.32, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Hella's median patient age at 60, with 56% women.

In 2024, Dr. Hella wrote 1,973 Medicare Part D claims for 223 patients. 84% of them were for generic drugs. CMS names the drug for 1,774 of them, across 35 drugs with 11 or more claims each, at $579,110 in total drug cost. In 2023, CMS named 1,241 claims across 36 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Hella for performance year 2024, reported as part of a group. Dr. Hella accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 2 papers to Dr. Hella in 2022. Dr. Hella's most frequent co-authors are Pouya Alexander Ameli, MD, MS, Marc-Alain Babi, MD and Maria Jose Bruzzone, MD.

CMS Open Payments shows 231 general payments to Dr. Hella from 49 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 91% of the total. Neuropace, Inc. paid the most, $841.

Dmand AI lists 1 award for Dr. Hella, most recently CMS Stage 1 EHR in 2013.

Dr. Hella graduated from University of Miami, Miller School of Medicine in 2006.

Dr. Hella is in network with 8 carriers, including Excellus BlueCross BlueShield, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.